1. The small GTP-binding Rho proteins are involved in the agonist-induced C
a2+ sensitization of smooth muscle. The action and the expression of Rnd1,
a new member of the Rho protein family constitutively bound to GTP, has bee
n studied in rat smooth muscle.
2. Recombinant prenylated Rnd1 (0.01-0.1 mg ml(-1)) dose dependently inhibi
ted carbachol- and GTP gamma S-induced Ca2+ sensitization in beta-escin-per
meabilized ileal smooth muscle strips but had no effect on the tension at s
ubmaximal [Ca2+] (pCa 6.3). Rnd1 inhibited GTP gamma S-induced tension with
out shifting the dose-response curves to GTP gamma S.
3. pCa-tension relationships were not modified by Rnd1 and the rise in tens
ion induced through the inhibition of myosin light chain phosphatase by cal
yculin A was not affected by Rnd1.
4. The C2+ sensitization induced by recombinant RhoA was completely abolish
ed when RhoA and Rnd1 were applied together.
5. Rnd1 was expressed at a low level in membrane fractions prepared from in
testinal or arterial smooth muscles. The expression of Rnd1 was strongly in
creased in ileal and aortic smooth muscle from rats treated with progestero
ne or oestrogen. Progesterone-treated ileal muscle strips showed a decrease
in agonist-induced Ca2+ sensitization.
6. The present study shows that (i) Rnd1 inhibits agonist- and GTP gamma S-
induced Ca2+ sensitization of smooth muscle by specifically interfering wit
h a RhoA-dependent mechanism and (ii) an increase in Rnd1 expression may ac
count, at least in part, for the steroid-induced decrease in agonist-induce
d C2+ sensitization.